Most of our Issues in Progress in Cardiovascular Diseases are Guest Edited by big-name experts on the Issue\'s particular topic. Often our Issues have a paper or two at the end on an important topic different than the theme for the Issue. However, due to so many important topics in the field of cardiovascular diseases (CVD) and the ability to attract top authors on so many different topics, at Progress in Cardiovascular Diseases (PCVD), we will start having probably one Issue per year on assorted topics in CVD, starting with this May/June 2020 Issue.

In this current Issue of PCVD, we have 2 commentaries, one on nutraceuticals for prevention and another on maintaining exercise in older people during a pandemic, and a research letter to the editor on the important high profile topic related to the coronavirus that is creating a tremendous current scare around the globe. These papers should generate interest outside of our current CVD readership. We also have 2 papers in this issue on the topic of heart transplantation (HT) from one of the leaders in the world, Dr. Mandeep Mehra from Harvard and Editor-in-Chief of the Journal of Heart and Lung Transplantation. One of the papers is on anticoagulation for the treatment of venous thromboembolism in HT and the other is on cardiac allograft vasculopathy, a topic that Dr. Mehra has worked on for nearly 3 decades and one that should be of high interest to many in CVD, especially specialists in advanced heart failure and HT.

There are many other unique topics in this Issue, including an analysis of the genetics of cardiorespiratory fitness, exercise in adolescents and adults with congenital heart disease, floppy mitral valve, cardiac sarcoidosis, cardiac imaging, especially with speckle tracking echocardiography, in rheumatological diseases, lipid treatments (non-statin and for Lpa), POTS, SGLT2 inhibitors for hypertension, endothelial function and update on dual anti-platelet therapy following percutaneous intervention, high intensive exercise training in patients with pulmonary embolism, estrogens in CVD, as well as a few other interesting topics which should be enjoyable to our readership.

Each June we get the updated Journal statistics,[@bb0005] ^,^ [@bb0010] so in the July/August Issue, I will provide the updated status of PCVD, at least regarding our Impact Factor and Elsevier Cite Score, which as usual are anxiously awaited.

I hope that our readership enjoys these assorted topics.Unlabelled Image
